Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Amortization of Deferred Charges (2019 - 2024)

ImmunityBio (IBRX) has disclosed Amortization of Deferred Charges for 4 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • Quarterly Amortization of Deferred Charges fell 29.66% to $5.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Sep 2025, down 79.73% year-over-year, with the annual reading at $22.6 million for FY2024, 46.72% down from the prior year.
  • Amortization of Deferred Charges for Q4 2024 was $5.0 million at ImmunityBio, down from $6.2 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $12.3 million in Q2 2023, with the low at $370000.0 in Q1 2022.
  • Average Amortization of Deferred Charges over 3 years is $6.8 million, with a median of $6.7 million recorded in 2023.
  • The sharpest move saw Amortization of Deferred Charges soared 3185.56% in 2023, then crashed 52.54% in 2024.
  • Over 3 years, Amortization of Deferred Charges stood at $7.8 million in 2022, then decreased by 8.2% to $7.1 million in 2023, then dropped by 29.66% to $5.0 million in 2024.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $5.0 million, $6.2 million, and $5.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.